Articles From: AMN Healthcare to Host 2014 Third Quarter Earnings Conference Call on Thursday, October 30, 2014 to AMRI SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Notifies Investors of Class Action Against Albany Molecular Research Inc. and Its Board of Directors and a Lead Plaintiff Deadline of January 12, 2015 -- AMRI


2014/10/21
Amorfix closes private placement and receives back rights for ALS antibody therapeutic development and commercialization Canada NewsWire TORONTO , Oct.
Sign-up for Amorfix closes private placement and receives back rights for ALS antibody therapeutic development and commercialization investment picks
2014/10/31
Ampco-Pittsburgh Corporation (NYSE: AP) announces sales for the three and nine months ended September 30, 2014 of $65,409,000 and $198,270,000, respectively, against $64,433,000 and $203,995,000 for the comparable prior year periods.
Sign-up for Ampco-Pittsburgh Announces Third Quarter Earnings investment picks
2014/9/22
Ampco-Pittsburgh Corporation (NYSE: AP) today announced the declaration of a regular quarterly dividend of eighteen cents ($.18) per share on the common stock of the Corporation.
Sign-up for Ampco-Pittsburgh Corporation Announces Regular Quarterly Dividend investment picks
RANCHO CUCAMONGA, Calif., Nov.
Sign-up for Amphastar Pharmaceuticals Reports Revenues of $59.7 Million for the Third Quarter Ended September 30, 2014 investment picks
RANCHO CUCAMONGA, Calif., Nov.
Sign-up for Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 12, 2014 investment picks
Amphenol now offers rugged switched copper and fiber-optic Ethernet products from 1Gbps to 10Gbps for the military, aerospace, and industrial markets SIDNEY, N.Y. , Sept.
Sign-up for Amphenol Aerospace High Speed Solutions Introduces Rugged Copper and Fiber-Optic Based Ethernet Switched and Media Converted Products investment picks
Amphenol Corporation (NYSE:APH) confirmed today that its Board of Directors approved the fourth quarter 2014 dividend on its Common Stock in the amount of $.125 per share at its meeting held on October 30, 2014.
Sign-up for Amphenol Announces Fourth Quarter 2014 Dividend Payment investment picks
2014/10/16
Updates of the 47 patient and 320 patient MI studies ENGLEWOOD, Colo.
Sign-up for Ampio Announces Results of the Open Label Portion of the Multiple Intra-articular Injections (MI) Study of Ampion™ in Patients with Osteoarthritis of the Knee at Week Twelve of the Trial investment picks
2014/12/4
ENGLEWOOD, Colo.
Sign-up for Ampio Pharmaceuticals to present at the Oppenheimer Annual Healthcare Conference on December 11th, 2014 investment picks
2014/11/12
ENGLEWOOD, Colo.
Sign-up for Ampio updates status of clinical trials and manufacturing facility investment picks
Levi & Korsinsky is investigating the Board of Directors of AmREIT, Inc. (“AmREIT” or “the Company”) (NYSE:AMRE) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Edens Investment Trust.
Sign-up for AMRE INVESTOR ALERT: Levi & Korsinsky, LLP Launches Investigation into the Board of Directors of AmREIT, Inc. Regarding the Fairness of the Sale of the Company to Edens Investment Trust -- AMRE investment picks
The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of AmREIT, Inc. (NYSE:AMRE) (“AmREIT”) in connection with the sale of the Company to Edens Investment Trust.
Sign-up for AMRE SHAREHOLDER ALERT: The Law Offices of Vincent Wong Launches Investigation of the Board of Directors of AmREIT, Inc. in Connection With the Fairness of the Sale of the Company to Edens Investment Trust – AMRE investment picks
AmREIT, Inc. (NYSE:AMRE) (“AmREIT” or the “Company”) today announced financial results for the third quarter ended September 30, 2014 and declared dividends for the fourth quarter ending December 31, 2014.
Sign-up for AmREIT Reports Third Quarter Results and Declares December 2014 Dividend investment picks
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of AmREIT, Inc. (“AmREIT”) (NYSE: AMRE) concerning the acquisition by Edens Investment Trust.
Sign-up for AmREIT Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Sale to Edens Investment Trust investment picks
AmREIT, Inc. (NYSE:AMRE) today announced that it has entered into a definitive agreement with Edens Investment Trust (“EDENS”) under which EDENS will acquire all outstanding shares of common stock of AmREIT for $26.55 per share in an all-cash transaction with a total enterprise value of approximately $763 million.
Sign-up for AmREIT to Be Acquired by EDENS for $26.55 Per Share investment picks
Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of AmREIT, Inc. NEW YORK , Nov.
Sign-up for AMREIT, INC. INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investigation of AmREIT, Inc. (AMRE) Over the Proposed Sale of the Company to Edens Investment Trust investment picks
2014/11/5
WILMINGTON, Del.
Sign-up for AMREIT, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout investment picks
2014/12/1
Rigrodsky & Long, P.A.: Do you own shares of AmREIT, Inc. (NYSE: AMRE )? Did you purchase any of your shares prior to October 31, 2014?
Sign-up for AMREIT, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout investment picks
PRINCETON, N.J. , Dec.
Sign-up for AMREP Reports Second Quarter Fiscal 2015 Results investment picks
ALBUQUERQUE, N.M. , Nov.
Sign-up for AMRI Announces Albuquerque, N.M. Manufacturing Facility Fully Operational investment picks
- Third quarter contract revenue of $57.5 million, up 8% from 2013 - Lower Discovery and API revenue is offset by addition of OsoBio - OsoBio business interruption contributes to third quarter adjusted loss per share of $(0.02) - Full year 2014 contract revenue expected to be between $253 and $261 million, an increase of 22% at the midpoint - Full year adjusted diluted EPS range between $0.67 and $0.73, compared to $0.70 in 2013 - Company provides initial 2015 outlook - Company creates new Drug Product reporting segment to reflect addition of OsoBio ALBANY, N.Y. , Nov.
Sign-up for AMRI Announces Third Quarter 2014 Results investment picks
ALBANY, N.Y. , Oct.
Sign-up for AMRI CEO to Present at the 2014 Credit Suisse Healthcare Conference investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: AMN Healthcare to Host 2014 Third Quarter Earnings Conference Call on Thursday, October 30, 2014 to AMRI SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Notifies Investors of Class Action Against Albany Molecular Research Inc. and Its Board of Directors and a Lead Plaintiff Deadline of January 12, 2015 -- AMRI
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent